Mission Connection (866-833-1822) has released a guide for first-time trazodone users, comparing the anti-anxiolytic's effects to other similar medications.
-- Mission Connection Healthcare has released a new guide on trazodone for individuals using the medication to address insomnia and sleeping issues related to depression, anxiety, and other mental illnesses. In the guide, experts at the treatment center compare the medication to other alternatives and cover possible side effects.
For more information, visit https://missionconnectionhealthcare.com/mental-health/sleep-aids/trazodone/
Originally approved by the FDA in 1981 as an antidepressant, trazodone has since become a common off-label prescription for sleep difficulties. The medication functions by adjusting serotonin levels while blocking specific receptors that influence sleep cycles. Clinical studies indicate that trazodone may enhance slow-wave sleep phases, which play a critical role in memory formation and brain function; research also suggests that at certain doses, the medication may assist patients with obstructive sleep apnea by decreasing interruptions throughout the night.
As Mission Connection's team of clinicians explains, trazodone works by blocking 5-HT2A receptors, which are associated with alertness and restlessness; alpha-1 receptors, which are responsible for “fight or flight” responses; and H1 histamine receptors, creating a calming effect similar to over-the-counter sleep aids.
These effects compound to lower blood pressure and heart rate, encouraging the body to shift from a state of alertness to a resting state, improving the quality of slow-wave sleep - the sleep phase associated with memory consolidation, emotional regulation, and protection against cognitive decline.
Due to trazodone’s effects on the body, it may cause orthostatic hypotension, mild dizziness, or minor headaches during the day. While the medication may also impact memory and movement over the longer term, the guide notes that this is rare, and the drug has comparatively fewer serious side effects than options such as benzodiazepines, Ambien, or Z-drugs. Additionally, because it does not bind the GABA receptors in the brain, trazodone is non-addictive, leading to a very low risk of dependence.
Mission Connection adds that patients may prefer trazodone to branded alternatives such as Lunesta or Belsomra, as it is more cost-effective. However, they must take care not to exceed recommended doses of the medication, as an overdose can lead to life-threatening conditions, such as serotonin syndrome. The guide advises readers to follow their physician’s guidelines to ensure they avoid any harmful side effects.
Interested parties can learn more by visiting https://missionconnectionhealthcare.com
Contact Info:
Name: Nathan Di Tomaso
Email: Send Email
Organization: Mission Connection
Address: 30310 Rancho Viejo Rd. , San Juan Capistrano, California 92675, United States
Website: https://missionconnectionhealthcare.com/
Source: PressCable
Release ID: 89169350
In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.
